7 completed, 4 unknown, 1 active not recruiting, 1 recruiting. 15 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 15 | Completed 7, Unknown 4, Active not recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 3 | Active not recruiting 1, Recruiting 1, Unknown 1 |
Follow Bleomycin: new trials by email Literature Review of Bleomycin trials Research Report on Bleomycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Controlled Trial to Evaluate the Effectiveness of Bleomycin and Cryotherapy in Treating Plantar Warts. Bleomycin injection, Cryotherapy - Verruca Plantaris | Phase 1 / Phase 2 | Recruiting | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 70 | 2024-12-25 | 2025-03-24 |
| Electrochemotherapy for Non-curable Gastric Cancer Bleomycin - Gastric Cancer | Phase 1 | Unknown | Zealand University Hospital | 8 | 2020-06-15 | 2020-08-20 |
| A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL) doxorubicin, Bleomycin, vinblastine - Hodgkin Lymphoma | Phase 1 / Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 82 | 2017-01-25 | 2026-02-17 |
| Dose Escalating Study for Amphinex-based PCI of Bleomycin. Amphinex, Bleomycin, Laser - Cutaneous or Sub-cutaneous Malignancies | Phase 1 | Completed | PCI Biotech AS | 3 | 2012-01-01 | 2014-06-16 |
| Electrochemotherapy as a Palliative Treatment for Brain Metastases The Electroporation System, Bleomycin - Brain Metastases, CNS Metastases | Phase 1 | Terminated | Copenhagen University Hospital at Herlev | 1 | 2011-04-01 | 2013-07-31 |
| A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma brentuximab vedotin, doxorubicin, vinblastine - Disease, Hodgkin | Phase 1 | Completed | Seagen Inc. | 51 | 2010-01-01 | 2014-12-18 |
| Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer Amphinex (TPCS2a), Bleomycin, Illumination with CeramOptec laser - Head and Neck Neoplasms, Skin Neoplasms | Phase 1 | Completed | PCI Biotech AS | 19 | 2009-08-01 | 2019-04-29 |
| Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma bleomycin sulfate, rituximab, prednisolone - Lymphoma | Phase 1 | Unknown | Lymphoma Trials Office | 2001-10-01 | 2013-09-20 | |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma bleomycin sulfate, filgrastim, cyclophosphamide - Lymphoma | Phase 1 / Phase 2 | Unknown | Lymphoma Trials Office | 30 | 2001-10-01 | 2013-09-20 |
| Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer bleomycin sulfate, electroporation therapy - Pancreatic Cancer | Phase 1 | Withdrawn | Ichor Medical Systems Incorporated | 2000-12-01 | 2012-09-19 | |
| Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma bleomycin sulfate, electroporation therapy - Melanoma (Skin) | Phase 1 | Unknown | H. Lee Moffitt Cancer Center and Research Institute | 2000-06-01 | 2013-09-17 | |
| A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma Bleomycin sulfate, Vincristine sulfate, Doxorubicin hydrochloride - Sarcoma, Kaposi, HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 24 | 2021-11-03 | |
| A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma Bleomycin sulfate, Vincristine sulfate, Doxorubicin hydrochloride - Sarcoma, Kaposi, HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 72 | 2021-10-29 | |
| A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS Bleomycin sulfate, Vincristine sulfate, Doxorubicin hydrochloride - Sarcoma, Kaposi, HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 36 | 2021-11-04 | |
| Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma Bleomycin sulfate, Vincristine sulfate, Doxorubicin hydrochloride - Lymphoma, Non-Hodgkin, HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 18 | 2021-11-02 |
Acquired Immunodeficiency Syndrome (4) · HIV Infections (4) · Lymphoma (3) · Sarcoma, Kaposi (3) · Head and Neck Neoplasms (2) · Hodgkin Disease (2) · Brain Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Squamous Cell (1) · Hematologic Diseases (1) · Lymphoma, Non-Hodgkin (1) · Melanoma (1) · Neoplasm Metastasis (1) · Nervous System Neoplasms (1) · Pancreatic Neoplasms (1)
National Institute of Allergy and Infectious Diseases (NIAID) (4) · Lymphoma Trials Office (2) · PCI Biotech AS (2) · Copenhagen University Hospital at Herlev (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Ichor Medical Systems Incorporated (1) · Memorial Sloan Kettering Cancer Center (1) · Seagen Inc. (1) · The Fourth Affiliated Hospital of Zhejiang University School of Medicine (1) · Zealand University Hospital (1)
United States (7) · United Kingdom (4) · Canada (2) · Denmark (2) · China (1)
Gill PS (2) · Ruth Pettengell, MD (2) · Alison Moskowitz, MD (1) · Colin Hopper, MD (1) · Julie Gehl, MD, DMSci (1) · Levine AM (1) · Martin Forster, MD (1) · Miles S (1) · Mitsuyasu RT (1) · Naomi Hunder, MD (1) · PS Gill (1) · Richard C. Karl, MD (1) · Ronald C. DeConti, MD (1) · S Miles (1) · Walsh C (1)